Rhabdomyolysis is caused by extensive damage to skeletal muscles resulting in elevated creatine phosphokinase (CPK), Lactate dehydrogenase (LDH), and aspartate aminotransferase (AST), leading to life-threatening consequences like acute renal failure, cardiac arrhythmias, and hyperthermia. A variety of causes for muscle damage are known, and one of the most common is drug-induced. Statins and many other agents are known to induce muscle damage, but here we report Entresto™ (Sacubitril/Valsartan) induced rhabdomyolysis which has not been previously reported as solely responsible in the literature.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Rawla, P., Raj, J. P., George, S. M., Nathala, P., & Vellipuram, A. R. (2019). A Rare Adverse Event of Rhabdomyolysis Caused by Sacubitril/Valsartan. Diseases, 7(2), 38. https://doi.org/10.3390/diseases7020038